Marinomed Biotech AG announced the appointment of Dr. Cornelia Kutzer as Chief Business Officer. Dr. Cornelia Kutzer brings over 20 years of experience in the pharmaceutical industry and will contribute to Marinomed's successful growth path. Most recently, she was CBO at AFFiRiS AG, where she was responsible for partnering efforts including a successful asset deal valued over $50 million.

As a consultant, she supported various clients during the ongoing COVID-19 pandemic in the global launch of their vaccines. Previously, she held positions in global marketing at Pfizer and Baxter as Senior Director Vaccines. Dr. Kutzer holds a PhD in pharmacology and toxicology from the Ludwig-Maximilians-Universit?t M?nchen, Germany, where she also completed her diploma in chemistry, and a postgraduate degree in business administration from the Technical University Munich.